Page 323 - AIDSBK23C
P. 323
Page 323
311 INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y,
Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, et al. Interleukin-2 therapy
in patients with HIV infection. N Engl J Med. 2009;361:1548-1559.
312 Duggan J, Peterson WS, Schutz M, Khuder S, Charkraborty J. Use of complementary and
alternative therapies in HIV-infected patients. AIDS Patient Care STDS. 2001;15:159-
167.
313 García-Lerma JG, Paxton L, Kilmarx PH, Heneine W. Oral pre-exposure prophylaxis for
HIV prevention. Trends Pharmacol Sci. 2010;31:74-81.
314 Grant RM, Lama JR, Anderson PL, et al. Preexposure Chemoprophylaxis for HIV
Prevention in Men Who Have Sex with Men. N Engl J Med. 2010;363:2587-2599.
315 McMichael AJ. HIV vaccines. Annu Rev Immunol. 2006;24:227-255.
316 D'Souza MP, Cairns JS, Plaeger SF. Current evidence and future directions for targeting
HIV entry. JAMA. 2000;284:215-222.
317 Durier C, Launay O, Meiffredy V, et al. Clinical safety of HIV lipopeptides used as
vaccines in healthy volunteers and HIV-infected adults. AIDS. 2006;20:1039-1049.
318 Walker BD, Burton DR. Toward an AIDS vaccine. Science. 2008;320(5877):760-764.
319 von Laer D, Hasselmann S, Hasselmann K. Gene therapy for HIV infection: what does it
need to make it work? J Gene Med. 2006;8:658-667.
320 Baden LR, Dolin R. The road to an effective HIV vaccine. N Engl J Med.
2012;366(14):1343-1344.
321 Hladik F, Doncel GF. Preventing mucosal HIV transmission with topical microbicides:
challenges and opportunities. Antiviral Res. 2010;88 Suppl 1:S3-9.
322 Briz V, Poveda E, Soriano V. HIV entry inhibitors: mechanisms of action and resistance
pathways. J Antimicrob Chemother. 2006;57:619-627.
323 Kahn JO, Cherng DW, Mayer K, Murray H, Lagakos S. Evaluation of HIV-1
immunogen, an immunologic modifier, administered to patients infected with HIV
having 300 to 549/microliter CD4 cell counts. JAMA. 2000;284:2193-2202.
324 Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The
challenge of finding a cure for HIV infection. Science. 2009;323(5919):1304-1307.
325 Le Douce V, Janossy A, Hallay H, Ali S, Riclet R, Rohr O, Schwartz C. Achieving a cure
for HIV infection: do we have reasons to be optimistic? J Antimicrob Chemother.
